share_log

名創優品:翌日披露報表

MNSO: Next Day Disclosure Return

香港交易所 ·  Jan 29 23:15
Summary by Moomoo AI
名創優品於2024年1月30日向香港聯合交易所有限公司提交翌日披露報表,披露其股份購回情況。報告顯示,名創優品在2023年12月8日至2024年1月29日期間,通過香港及紐約證券交易所購回共計2,715,868股普通股,但未進行註銷。其中,最大宗的單次購回發生於2024年1月29日,當日在紐約證券交易所購回426,000股,涉及金額達14,974,837.48港元。該公司確認,所有購回行為均獲董事會授權批准,並符合相關上市規則的要求。
名創優品於2024年1月30日向香港聯合交易所有限公司提交翌日披露報表,披露其股份購回情況。報告顯示,名創優品在2023年12月8日至2024年1月29日期間,通過香港及紐約證券交易所購回共計2,715,868股普通股,但未進行註銷。其中,最大宗的單次購回發生於2024年1月29日,當日在紐約證券交易所購回426,000股,涉及金額達14,974,837.48港元。該公司確認,所有購回行為均獲董事會授權批准,並符合相關上市規則的要求。
MIGUO PREMIUM FILED A NEXT DAY DISCLOSURE REPORT WITH THE HONG KONG UNITED EXCHANGE LIMITED ON 30 JANUARY 2024 TO DISCLOSE ITS SHARE REPURCHASE STATUS. The report shows that between December 8, 2023 and January 29, 2024, NTSU repurchased a total of 2,715,868 shares of ordinary shares through the Hong Kong and New York Stock Exchanges, but was not delisted. Of these, the largest single repurchase occurred on 29 January 2024, when 426,000 shares were repurchased on the New York Stock Exchange on the New York Stock Exchange for an amount of HK$14,974,837.48. The Company confirms that all repurchases are authorized by the Board of Directors and comply with the requirements of the relevant Listing Rules.
MIGUO PREMIUM FILED A NEXT DAY DISCLOSURE REPORT WITH THE HONG KONG UNITED EXCHANGE LIMITED ON 30 JANUARY 2024 TO DISCLOSE ITS SHARE REPURCHASE STATUS. The report shows that between December 8, 2023 and January 29, 2024, NTSU repurchased a total of 2,715,868 shares of ordinary shares through the Hong Kong and New York Stock Exchanges, but was not delisted. Of these, the largest single repurchase occurred on 29 January 2024, when 426,000 shares were repurchased on the New York Stock Exchange on the New York Stock Exchange for an amount of HK$14,974,837.48. The Company confirms that all repurchases are authorized by the Board of Directors and comply with the requirements of the relevant Listing Rules.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more